Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-057052

EVP, Chief Medical Officer sold 589 shares at $19.46 ($11,462)

  • EVP, Chief Medical Officer acquired 2,413 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-11 Exercise or conversion : show line 1 in the form +2,413 43,172 D
2020-07-15 Sale : show line 2 in the form −589 $19.46 $11,462 43,229 D
Open-market sales · 589 sh · avg $19.46 · $11,462

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-07-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,413 2,413 7,237 D
Loading xslF345X03/doc4.xml…